Nine Chapters Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Nine Chapters Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-32,400	Closed	-$211K	–	201
2017 Q1	$211K	Buy	32,400 +19,600	+153%	+$110K	0.28%	150
2016 Q4	$57K	Buy	+12,800	New	+$53.7K	0.1%	160
2016 Q3	–	Sell	-10,200	Closed	-$67K	–	84
2016 Q2	$67K	Buy	+10,200	New	+$72.1K	1.4%	23
2015 Q4	–	Sell	-83,400	Closed	-$499K	–	627
2015 Q3	$499K	Buy	+83,400	New	+$579K	0.04%	566
2015 Q2	–	Sell	-164,600	Closed	-$999K	–	1187
2015 Q1	$999K	Sell	164,600 -59,600	-27%	-$397K	0.08%	375
2014 Q4	$1.55M	Buy	224,200 +125,400	+127%	+$922K	0.13%	212
2014 Q3	$804K	Buy	98,800 +68,400	+225%	+$535K	0.07%	368
2014 Q2	$247K	Buy	+30,400	New	+$231K	0.02%	774

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nine Chapters Capital Management's SPPI Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2017, closing a stake of 32,400 shares — an estimated $211K sold.

Nine Chapters Capital Management first reported a position in SPPI in Q2 2014 and held it in 8 quarters. The position peaked at $1.55M in Q4 2014. 124 funds tracked by Wall St. Rank hold SPPI as of Q2 2017.

Nine Chapters Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
Nine Chapters Capital Management sold 32,400 Spectrum Pharmaceuticals Inc shares in Q2 2017, an estimated $211K.
Nine Chapters Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2014 and held it in 8 quarters.
Nine Chapters Capital Management's Spectrum Pharmaceuticals Inc position peaked at $1.55M in Q4 2014.
124 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.